NDC 70518-2823
Insulin Aspart
Insulin Aspart
Insulin Aspart is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Insulin Aspart.
| Product ID | 70518-2823_acc89624-0c49-ebc5-e053-2a95a90a6aba |
| NDC | 70518-2823 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Insulin Aspart |
| Generic Name | Insulin Aspart |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2020-08-03 |
| Marketing Category | BLA / BLA |
| Application Number | BLA020986 |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | INSULIN ASPART |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [CS],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |